Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

NCT07221370 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Clostridium Difficile Infection
Vancomycin Resistant Enterococci Infection

Interventions

DRUG: Vancomycin 125mg
DRUG: Placebo

Sponsor

Riverside University Health System Medical Center